This study of 1350 patients with acute myocardial infarction admitted to several hospitals during a 10-year period attempts to answer several questions currently in dispute: the correlation of the patient's condition on admission with the mortality rate, the relation of the patient's age to prognosis, and the value of routine anticoagulant therapy. It presents the major statistical objections to the study by the Committee for the Evaluation of Anticoagulants of the American Heart Association, questions the evidence upon which the Committee made its recommendations and concludes that incontrovertible proof of the advantages of routine anticoagulant therapy in patients mildly ill on admission to the hospital has not been presented thus far.
proach, the only adequate method of study, is fraught with many dangers which may lead to incorrect interpretation. Thus, in spite of a plethora of papers in the literature, the value of and indications for routine anticoagulant therapy* are still in doubt." 2 Even among thoset who participated in the anticoagulant study sponsored by the American Heart Association in 1948, 4 there is no present unanimity of opinion. All investigators are aware that the patient's condition prior to therapy has a defiFrom the Department of Medicine, Baylor Uni- nite influence upon the mortality rate, but the exact role of this factor has been difficult to assess because of inability to express it quantitatively. This has led to uncertainty as to whether control and treated groups are equally ill and, therefore, whether any difference in mortality found at the conclusion of a study was due to unequal selection of cases or to the specific therapy employed. Until a few years ago the patient's age had been accepted as an important factor in mortality due to acute coronary thrombosis.5' 6 The Committee for the Evaluation of Anticoagulants of the American Heart Associationt observed that routine anticoagulant therapy was effective in lowering the mortality rate in the older age group, but did not alter the rate in those under 60 years of age. Russek2' 7 recently has raised serious doubts concerning the validity of the age factor iil prognosis and routine anticoagulant therapy in general. Thus it is obvious that certain basic facts regarding mortality statistics in acute coronary thrombosis with myocardial infarction require elucidation; that the status of anticoagulant therapy is still unsettled; and that new technics for more adequate study might be required to resolve the points at issue. This investigation, designed to answer several Associated serious diseases [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Diabetes . [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Congestive Failure [20] [21] [22] [23] [24] [25] Uremia. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Urinary tract infection .10 Serious Arrhythmias Emphysema.10
Occas. vent [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Freq. Congestive failure . [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Examples:
Patient entered in shock (40) with history of previous hypertension (10) and mild diabetes (10) P. I. R. -60. Patient entered in shock (40), congestive failure (20) and ventricular tachycardia (40) with history of hypertension (10) and previous severe coronary occlusion (30) P. I. R. -140.
Patient entered with negative findings (no shock, congestive failure, arrhythmia or associated serious disease) with history of hypertension (10) P. 1. R. -10. of the preceding questions and to examine some questionable statistical pitals using anticoagulant therapy during the year 1950 was studied and compared with the average mortality rate in each hospital the previous 10 years. In one hospital there was a large enough group of patients who received no anticoagulants so that comparison could be made with the anticoagulant group. In this study the mortality rate and percentage of patients in each pathologic index rating group was determined. The average pathologic index rating for each hospital was calculated, and the theoretical or expected mortality rate corresponding to this rating was determined by using the preanticoagulant era Jefferson Davis Hospital mortality study as a basis. The actual rate in 1950 was then compared with the expected mortality rate. average mortality rate which is largely dependent upon its criteria for admission and the type of patients treated. The yearly rate, however, in each hospital will vary widely and will depend upon the proportion of seriously ill admitted for that particular year-in addition to the chance variation of small samples. This would indicate that any study which draws the younger age groups. t A greater proportion of younger persons is in the lower pathologic index rating groups, while older persons are more likely to have higher pathologic index ratings. Young persons with high pathologic index ratings have higher mortality rates than older persons with low index ratings. Comment. Crude mortality statistics indicate that with increasing age there is increased mortality from acute myocardial infarction. In the past this has seemed to indicate that the patient's age is an important factor in causing of 75, when the rate is doubled. To determine whether the patient's age significantly affects recovery from any disease, the nonspecific increasing death rate associated with advancing age must first be discounted. The reason a higher proportion of older persons are in the higher pathologic index rating groups is probably due to the fact that they have had more years to develop the ills and infirmities that increase the pathologic index rating and lower life expectancy. Thus it would appear that a man 60 years of age would have approximately the (56) and the sex ratio is similar (3:1l), the mortality rate in series B will be "significantly" greater than in series A because of the preponderance of elderly females with high mortality in that group. The difference in the rate would therefore be due to an unusual "selection" of cases which would not be disclosed by computing the average age or sex ratio.
The disagreement between the conclusions of the Committee of the American Heart Association and Russek concerning the subject of age and prognosis is apparently an illusion, since each has viewed the problem from a different aspect. The findings in this study confirm several of their observations and may be summarized as follows: (1) The average age of seriously ill patients admitted to the hospital is higher than the age of those less seriously ill and this is reflected generally in a higher mortality rate in the older age group. (2) A greater proportion of the younger age group is found to be mildly ill on admission, in contrast to the older age group, the majority of whom are likely to be more seriously ill. (3) The average age of female patients is higher than male patients generally, and probably in the five groups which reflect increasing severity of illness. (4) In patients who are equally ill on admission, no unusual difference in the mortality rate from this disease is found between any of the age groups except in those above 75 years of age when the rate appears to be doubled. (5) Seriously ill young persons have a higher mortality rate than less seriously ill older patients. (6) The condition of the patient oln admission to the hospital is a vastly more important determinant of prognosis than the patient's age.
This study suggests an additional interpretation of the Committee's observation that anticoagulants were effective in lowering the mortality rate in those above 60 years of age, whereas there was no significant decrease in mortality in the younger age group. Since it has been shown that age reflects severity of illness on admission to the hospital, it would appear that routine anticoagulant therapy had no effect upon the mortality rate in the mildly ill, but may have been effective in lowering the rate in the seriously ill. Actually, this analysis of their findings parallels the judgment of many experienced clinicians who do not favor routine anticoagulant therapy for mildly ill patients, but believe it may be prescribed for those seriously ill without regard to age. This policy, which is compatible with the Committee's findings, would appear to be preferred to any indications for therapy based primarily or solely upon the age of the patient. 496 daily determinations were outside of what is generally considered to be the "effective" range which is 10 per cent to 24 per cent activity.* Actually, the precise range in which clotting will be inhibited in vivo is uncertain and still remains a matter of clinical conjecture. In none of the 30 cases was the prothrombin activity within the effective range during the entire course of therapy. The extreme variability of response of patients receiving an identical dose of Dicumarol and the inability to predict in advance the effect of a given dose upon the prothrombin time were confirmed in this study. These findings might also indicate that in this community because many physicians are not completely convinced of the value of this therapy or are concerned about its dangers,t it is prescribed half-heartedly and only because such treatment is "expected." The following conclusions would appear to be valid: (1) It was most difficult to maintain the prothrombin activity within the prescribed range. (2) Patients were "protected" less than half the time while under therapy and were predisposed to hemorrhage approximately one day per week. (3) Since all patients had one or more determinations outside the effective range, the occurrence of a thromboembolic episode during therapy could always be explained by anticoagulant enthusiasts.
Results of Anticoagulant Therapy
It may be concluded, therefore, that the absence of a significant difference in mortality between the group receiving anticoagulants and the control groups in this study may Table 7 summarizes the Houston findings and compares them with the Committee's initial report. In all items studied there appears to be no significant difference between the odd and even day groups. It confirms previous reports that the average age of females with acute coronary thrombosis is greater than males, and approximately three of every four cases are males. The distribution of cases between the odd and even days is in accord with what should be expected in a random sampling from a single universe without selection: viz., the expected number of patients in the even group is 1.1 times the standard error of the theoretic number.
Comment. Recent objections have been raised to the Committee's studies because of the probability that the cases in this study were not selected at random. Rytand,'6 in discussing the Committee's follow-up report'6 in which the odd day or treated group consisted of 589 cases, and the even day or control group consisted of 442 cases, noted that the excess of treated cases was 3.9 times the standard error of the theoretical number expected in a complete random selection of cases. Anything beyond 3 times the standard error is considered significant, cannot be attributed to chance, and indicates the likelihood of selection of cases, rather than random sampling. "Frequencies differing from the expected frequency by more than 3 times the standard error are almost certainly not due to fluctuations of sampling. They point to some departure of the sampling from simplicity, which may in turn point either to some flaw in the sampling technique or to causal effects in the universe itself."'7 Since a comparable study of a similar universe in Houston yielded a probable error well within the range expected of a random sampling, it may be concluded that the Committee's figures are not due "to causal effects in the universe itself" but rather "to some flaw in the sampling technique." This objection, if sustained, would invalidate, or at least cast suspicion upon the conclusions derived from the study made by the Anticoagulant Committee.
The difference in mortality rate in the American Heart Association study between the treated and untreated group is 7.4 per cent (23.4 per cent mortality in controls and 16 per cent in the treated group). It has been shown in our study that in a single hospital the mortality rate varied from 8 per cent to 95 per cent, a difference of 87 per cent, by selecting cases according to the degree of severity of illness on admission. In addition, the mortality rate from this disease reported in the literature has ranged from 8 thrombosis the greater are the chances of recovery, and the established fact that the highest mortality rate occurs during the first week when determined by any statistical method. The treated group, however, showed the expected type of curve. One could well argue that since the mortality rate in the control group in the Committee's study does not coincide with the curve expected from past clinical experience, this may be additional evidence of the presence of a selected group, rather than a random sampling.
The difference in the mortality rate between the treated and control groups, according to the Committee, is due to deaths from thromboembolism. It is generally agreed that the clinical diagnosis of several thromboembolic phenomena is difficult, often inaccurate, subject to errors of omission and commission and directly related to the examiner's index of suspicion.*20 Thus far, no postmortem studies have been presented to confirm those impressions relating to the increased incidence of fatal thromboembolism in the control group, nor has there been any mention of the accuracy of clinical diagnosis of nonfatal thromboembolism as verified by surgical and autopsy studies. It would appear, therefore, that since the crucial evidence has not been produced to date, any conclusions regarding this aspect of the Com-* Superficial thrombophlebitis, cerebral and peripheral arterial emboli can generally he accurately diagnosed. However secondary myocardial infarctions due to extension, pulmonary infarction especially in the presence of myocardial failure and pulmonary congestion, and phlebothrombosis are subject to diagnostic errors. In the study by the Committee on Anticoagulants 18 per cent of thromboembolic episodes in the control group were of the easily diagnosed variety, whereas 82 per cent were of the difficult type. In the treated group the decrease in thromboembolism appears to be almost completely confined to the group in which the diagnosis is often questionable. A possible additional psychologic source of error is the unconscious bias of the medical examiner due to his increased suspicion of the presence of thromboembolism in patients not receiving anticoagulants, and the likelihood of an excessive number of potentially misdiagnosed psychosomatic complaints in "control" patients anxious about not receiving the "clot removing" drug. In a properly controlled study using the "blind" technic neither the examining physician nor the subject would be aware of the group to which the patient is assigned until the study had been concluded. 18 mittee's report can only be accepted with reservations at this time.
DISCUSSION AND CONCLUSIONS 1. A method for quantitative determination of degrees of illness in acute myocardial infarction is presented and termed "pathologic index rating."
2. The Pathologic Index Rating, determined on admission to the hospital, is found to be closely related to the mortality rate. In one hospital the mortality rate ranged from 8 per cent in the mildest group to 95 per cent in the critically ill group.
3. The average yearly mortality rate for acute myocardial infarction over a period of years in a designated hospital is a reflection of its criteria for admission and the type of patient treated. The yearly mortality rate varies widely and depends upon the proportion of seriously ill admitted to the total number admitted for that particular year.
4. Age as a prognostic factor in acute myocardial infarction has little significance, except as it may indicate a more serious condition on admission to the hospital. In patients who are equally ill on admission, no important difference in the mortality rate is found between any of the age groups except in those above 75 years of age when the rate is doubled. Older persons have higher crude mortality rates because a greater proportion are seriously ill on admission.
5. The mortality rate of patients treated with anticoagulants in three hospitals during 1950 was similar to the average mortality in each during the preceding 10 years. In one hospital a comparison of the treated and untreated groups with similar pathologic index ratings showed no significant differences in mortality. The mean pathologic index rating for each hospital was determined, and the mortality rate corresponding to it in the preanticoagulant days was found to be similar to the actual mortality rate in 1950 following the use of anticoagulant therapy. 6 . In a random selection of patients in this community receiving anticoagulant therapy, 66 per cent of all daily prothrombin determinations were found to be outside the effective range, and during one day each week patients were predisposed to hemorrhage.
7. There would appear to be insufficient reason to use anticoagulant therapy in the low (8 per cent) mortality group. If one of every four deaths from acute coronary thrombosis is due to thromboembolism, then theoretically only two out of 100 patients in this group may be saved.* However, since anticoagulants in practice are neither 100 per cent efficient, nor effectively used, possibly at most only one death in 100 may be prevented, whereas two patients would be expected to have major hemorrhage.22 Routine anticoagulant therapy in this group, therefore, would subject 99 patients to the danger, inconvenience and expense of the treatment, in order to possibly prevent one fatality. In addition, the Committee's study appears to indicate that anticoagulants had no effect upon the mortality rate in the mildly ill.
8 between two groups is probably not due to chance, but rather to some other factor which could be unequal selection of cases, special attention to one group, etc., as well as the use of particular drugs. When statistical significance has been shown, it then becomes imperative to determine whether any one of the many factors affecting mortality is responsible for the difference before it can be attributed to the drug or procedure under investigation.
9. Certain objections to the Committee's study were raised: (a) Cases in the treated and untreated groups do not appear to be random selections. (b) It was not shown conclusively that the control and treated cases were of equal severity. (c) Mortality statistics by weeks of illness in the control group were not in accord with past experience. (d) The clinical diagnosis of thromboembolism is difficult, often inaccurate, subject to errors of both commission and omission and directly related to the examiner's index of suspicion. Conclusions from statistics based upon questionable data, without pathologic confirmation, can only be accepted with reservations. (e) No postmortem studies have been published to support the statement that the difference in the mortality rate between the treated and untreated groups was due to an increased incidence of fatal thromboembolism in the untreated group. SUMMARY 1. No adequately controlled, statistically valid study has been published to date which indicates unequivocally that routine anticoagulant therapy in acute myocardial infarction decreases the mortality rate in all classes of patients from the mildly ill to the seriously ill.
2. The published reports of reduced incidence of thromboembolism in treated groups as compared with control groups have not conclusively demonstrated that the decrease is wholly attributable to anticoagulant therapy rather than to such other factors as erroneous diagnosis, unconscious bias of the medical examiner and deviations from the stringent requirements of truly controlled studies.
3. Unless additional evidence to the contrary is presented, there would appear to be little reason to prescribe anticoagulants routinely in persons who are mildly ill in view of the low mortality, as opposed to the expense, inconvenience, dangers and the universal difficulty of maintaining constantly "effective" prothrombin blood levels due to present inadequate drugs and/or other factors.
4. In the more seriously ill patients, the theoretical advantages of anticoagulant therapy justify this treatment even though there may be some question as to whether its value has been clearly demonstrated. 
ACKNOWLEDGMENTS

